Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival

Epidemiologic Reviews

Volumn 37, Issue 1, 2015, Pages 55-70

  Beard, John D ^a,b   Kamel, Freya ^b  

^a IL   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Amyotrophic lateral sclerosis; Gulf War; Incidence; Military personnel; Mortality; Motor neuron disease; Occupational exposure; Veterans

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ENVIRONMENTAL EXPOSURE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MILITARY DEPLOYMENT; MILITARY SERVICE; MOTOR NEURON DISEASE; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SURVIVAL; UNITED STATES; VETERAN; WAR; ADVERSE EFFECTS; EUROPE; INCIDENCE; MORTALITY; RISK FACTOR; SOLDIER; STATISTICS AND NUMERICAL DATA;

AMYOTROPHIC LATERAL SCLEROSIS; EUROPE; HUMANS; INCIDENCE; MILITARY PERSONNEL; OCCUPATIONAL EXPOSURE; RISK FACTORS; UNITED STATES;

EID: 84930423950     PISSN: 0193936X     EISSN: 14786729     Source Type: Journal    
DOI: 10.1093/epirev/mxu001     Document Type: Article

References (78)

1. Armon C. Amyotrophic lateral sclerosis. In: Nelson LM, Tanner CM, Van Den Eeden SK, et al., eds. Neuroepidemiology: From Principles to Practice. New York, NY: Oxford University Press; 2004:162-187.
2. Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369(9578):2031-2041.
3. Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.
4. National Center for Health Statistics, Centers for Disease Control and Prevention. About underlying cause of death, 1999-2011. http://wonder. cdc. gov/ucd-icd10. html. Accessed July 22, 2014.
5. Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev. 2012;3:CD001447.
6. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245-256.
7. Deng HX, Chen W, Hong ST, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477(7363):211-215.
8. Kwiatkowski TJ Jr, BoscoDA, LeclercAL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323(5918):1205-1208.
9. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130-133.
10. Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257-268.
11. Vance C, Rogelj B, Hortobágyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323(5918):1208-1211.
12. Armon C. Smoking may be considered an established risk factor for sporadic ALS. Neurology. 2009;73(20):1693-1698.
13. Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68(13):1002-1007.
14. Fang F, Quinlan P, Ye W, et al. Workplace exposures and the risk of amyotrophic lateral sclerosis. Environ Health Perspect. 2009;117(9):1387-1392.
15. McGuire V, Longstreth WT Jr, Nelson LM, et al. Occupational exposures and amyotrophic lateral sclerosis: a population-based case-control study. Am J Epidemiol. 1997;145(12):1076-1088.
16. Alonso A, Logroscino G, Jick SS, et al. Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study. BMC Neurol. 2010;10:6.
17. Chiò A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10(5-6): 310-323.
18. Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol. 2006;253(11):1428-1436.
19. Czaplinski A, Yen AA, Simpson EP, et al. Predictability of disease progression in amyotrophic lateral sclerosis. Muscle Nerve. 2006;34(6):702-708.
20. Gil J, Preux PM, Alioum A, et al. Disease progression and survival in ALS: first multi-state model approach. Amyotroph Lateral Scler. 2007;8(4):224-229.
21. Gordon PH, Cheng B, Salachas F, et al. Progression in ALS is not linear but is curvilinear. J Neurol. 2010;257(10):1713-1717.
22. Mandrioli J, Faglioni P, Nichelli P, et al. Amyotrophic lateral sclerosis: prognostic indicators of survival. Amyotroph Lateral Scler. 2006;7(4):211-220.
23. Paillisse C, Lacomblez L, Dib M, et al. Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6(1):37-44.
24. Pastula DM, Coffman CJ, Allen KD, et al. Factors associated with survival in the National Registry of Veterans with ALS. Amyotroph Lateral Scler. 2009;10(5-6):332-338.
25. Ganesalingam J, Stahl D, Wijesekera L, et al. Latent cluster analysis of ALS phenotypes identifies prognostically differing groups. PLoS One. 2009;4(9):e7107.
26. Qureshi MM, Hayden D, Urbinelli L, et al. Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler. 2006;7(3):173-182.
27. Kaufmann P, Levy G, Thompson JL, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology. 2005;64(1):38-43.
28. Süssmuth SD, Sperfeld AD, Hinz A, et al. CSF glial markers correlate with survival in amyotrophic lateral sclerosis. Neurology. 2010;74(12):982-987.
29. Rauchway AC, Kaiboriboon K, Bansal SK, et al. A role for functional classification in the early identification of prognostic factors in ALS. Amyotroph Lateral Scler. 2007;8(4):214-216.
30. Bureau of the Census, US Department of Commerce. Veteran status. 2012 American Community Survey 1-year estimates. Washington, DC: Bureau of the Census; 2012. http://factfinder2. census. gov/faces/tableservices/jsf/pages/productview. xhtml? pid=ACS- 12-1YR-S2101&prodType=table. Accessed July 22, 2014.
31. National Center for Veterans Analysis and Statistics, US Department of Veterans Affairs. National Survey of Veterans, Active Duty Service Members, Demobilized National Guardand Reserve Members, Family Members, and Surviving Spouses. Rockville, MD: Westat, Inc.; 2010.
32. Hernandez LM, Durch JS, Blazer DG 2nd, et al., eds. Institute of Medicine. Gulf War Veterans: Measuring Health. Washington, DC: National Academies Press; 1999.
33. Hoerster KD, Lehavot K, Simpson T, et al. Health and health behavior differences: U. S. military, veteran, and civilian men. Am J Prev Med. 2012;43(5):483-489.
34. Institute of Medicine of the National Academies. Amyotrophic Lateral Sclerosis in Veterans: Review of the Scientific Literature. Washington, DC: National Academies Press; 2006.
35. Institute of Medicine of the National Academies. About reports. Washington, DC: Institute of Medicine of the National Academies; 2014. http://www. iom. edu/Reports. aspx. Updated July 18, 2014. Accessed March 6, 2014.
36. Coffman CJ, Horner RD, Grambow SC, et al. Estimating the occurrence of amyotrophic lateral sclerosis among Gulf War (1990-1991) veterans using capture-recapture methods. Neuroepidemiology. 2005;24(3):141-150.
37. Haley RW. Excess incidence of ALS in young Gulf War veterans. Neurology. 2003;61(6):750-756.
38. Horner RD, Kamins KG, Feussner JR, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003;61(6):742-749.
39. Kang HK, Bullman TA. Mortality among US veterans of the Persian Gulf War: 7-year follow-up. Am J Epidemiol. 2001; 154(5):399-405.
40. Smith TC, Gray GC, Knoke JD. Is systemic lupus erythematosus, amyotrophic lateral sclerosis, or fibromyalgia associated with Persian Gulf War service? An examination of Department of Defense hospitalization data. Am J Epidemiol. 2000;151(11):1053-1059.
41. Weisskopf MG, O'Reilly EJ, McCullough ML, et al. Prospective study of military service and mortality from ALS. Neurology. 2005;64(1):32-37.
42. Gibberd FB, Simmonds JP. Neurological disease in ex-Far-East prisoners of war. Lancet. 1980;2(8186):135-137.
43. Thomas TL, Kang HK. Mortality and morbidity among Army Chemical Corps Vietnam veterans: a preliminary report. Am J Ind Med. 1990;18(6):665-673.
44. Chió A, Meineri P, Tribolo A, et al. Risk factors in motor neuron disease: a case-control study. Neuroepidemiology. 1991;10(4):174-184.
45. Gresham LS, Molgaard CA, Golbeck AL, et al. Amyotrophic lateral sclerosis and occupational heavy metal exposure: a case-control study. Neuroepidemiology. 1986;5(1):29-38.
46. Gunnarsson LG, Lindberg G, Söderfeldt B, et al. Amyotrophic lateral sclerosis in Sweden in relation to occupation. Acta Neurol Scand. 1991;83(6):394-398.
47. Sutedja NA, Veldink JH, Fischer K, et al. Lifetime occupation, education, smoking, and risk of ALS. Neurology. 2007;69(15): 1508-1514.
48. Holloway SM, Mitchell JD. Motor neurone disease in the Lothian Region of Scotland 1961-81. J Epidemiol Community Health. 1986;40(4):344-350.
49. Drouet A, Desjeux G, Balaire C, et al. Retrospective study of ALS in French military personnel [abstract]. Rev Neurol (Paris). 2010;166(6-7):621-629.
50. Barth SK, Kang HK, Bullman TA, et al. Neurological mortality among U. S. veterans of the Persian Gulf War: 13-year follow-up. Am J Ind Med. 2009;52(9):663-670.
51. Horner RD, Grambow SC, Coffman CJ, et al. Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreak. Neuroepidemiology. 2008;31(1):28-32.
52. Gale CR, Braidwood EA, Winter PD, et al. Mortality from Parkinson's disease and other causes in men who were prisoners of war in the Far East. Lancet. 1999;354(9196): 2116-2118.
53. Miranda ML, Overstreet Galeano MA, Tassone E, et al. Spatial analysis of the etiology of amyotrophic lateral sclerosis among 1991 GulfWar veterans. Neurotoxicology. 2008;29(6):964-970.
54. Winkenwerder W Jr. US demolition operations at Khamisiyah: final report. Washington, DC: Office of the Assistant Secretary of Defense (Health Affairs) and Special Assistant to the Under Secretary of Defense (Personnel and Readiness) for Gulf War Illnesses, Medical Readiness, and Military Deployments, US Department of Defense; 2002.
55. Rostker B. Environmental exposure report: oil well fires. Washington, DC: Office of the Special Assistant to the Deputy Secretary of Defense for GulfWar Illnesses, US Department of Defense; 2000.
56. Binazzi A, Belli S, Uccelli R, et al. An exploratory case-control study on spinal and bulbar forms of amyotrophic lateral sclerosis in the province of Rome. Amyotroph Lateral Scler. 2009;10(5-6):361-369.
57. White DL, Harati Y, del Junco D, et al. ALS/MND and veterans: are vets at increased risk [abstract]. J Neurol Sci. 2002;199(suppl 1):S46.
58. Kondo K, Tsubaki T. Case-control studies of motor neuron disease: association with mechanical injuries. Arch Neurol. 1981;38(4):220-226.
59. Kurtzke JF, Beebe GW. Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths. Neurology. 1980;30(5):453-462.
60. Kwee LC, Allen KD, Oddone EZ, et al. Examination of paraoxonase gene cluster and VietNam deployment in amyotrophic lateral sclerosis [abstract]. Neuroepidemiology. 2009;33(1):71-72.
61. Nicolson GL, Nasralla MY, Haier J, et al. High frequency of systemic mycoplasmal infections in Gulf War veterans and civilians with amyotrophic lateral sclerosis (ALS). J Clin Neurosci. 2002;9(5):525-529.
62. Schulte PA, Burnett CA, Boeniger MF, et al. Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991. AmJ PublicHealth. 1996;86(9):1281-1288.
63. Brooks BR, Anderson FA, Gowda N, et al. Amyotrophic lateral sclerosis (ALS) outcomes in US military veterans compared with non-veterans: neuroepidemiological insights from the ALS CARE Database [abstract]. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4(suppl 1):114.
64. Kasarskis EJ, Lindquist JH, Coffman CJ, et al. Clinical aspects of ALS in Gulf War veterans. Amyotroph Lateral Scler. 2009; 10(1):35-41.
65. Miller RG, Anderson FA Jr, Bradley WG, et al. The ALS Patient Care Database: goals, design, and early results. ALS C. A. R. E. Study Group. Neurology. 2000;54(1):53-57.
66. US Census Bureau. Census 2000 summary file 3. Washington, DC: Bureau of the Census, US Department of Commerce; 2014. http://factfinder2. census. gov/faces/tableservices/jsf/ pages/productview. xhtml?pid=DEC-00-SF3-P039&prod Type=table. Accessed July 22, 2014.
67. Dick S, Semple S, Dick F, et al. Occupational titles as risk factors for Parkinson's disease. Occup Med (Lond). 2007;57(1): 50-56.
68. McLaughlin JK, Mehl ES. A comparison of occupational data from death certificates and interviews. Am J Ind Med. 1991; 20(3):335-342.
69. Marin B, Couratier P, Preux PM, et al. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology. 2011;36(1):29-38.
70. Dean G, Quigley M, Goldacre M. Motor neuron disease in a defined English population: estimates of incidence andmortality. J Neurol Neurosurg Psychiatry. 1994;57(4): 450-454.
71. Fong KY, Yu YL, Chan YW, et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology. 1996;15(5):239-245.
72. Rothman KJ, Greenland S, Lash TL. Cohort studies. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:100-110.
73. Lash TL, Cole SR. Immortal person-time in studies of cancer outcomes. J Clin Oncol. 2009;27(23):e55-e56.
74. Allen KD, Kasarskis EJ, Bedlack RS, et al. The National Registry of Veterans with Amyotrophic Lateral Sclerosis. Neuroepidemiology. 2008;30(3):180-190.
75. Kasarkis EJ, Dominic K, Oddone EZ. The National Registry of Veterans with Amyotrophic Lateral Sclerosis: Department of Veterans Affairs Cooperative Studies Program (CSP) #500a. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5(suppl 1):129-132.
76. Schmidt S, Allen KD, Loiacono VT, et al. Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA Study. Rationale, study design and demographic characteristics. Neuroepidemiology. 2008; 30(3):191-204.
77. Teschke K, Olshan AF, Daniels JL, et al. Occupational exposure assessment in case-control studies: opportunities for improvement. Occup Environ Med. 2002;59(9): 575-593.
78. McGuire V, Longstreth WT Jr, Koepsell TD, et al. Incidence of amyotrophic lateral sclerosis in three counties in western Washington State. Neurology. 1996;47(2): 571-573.